Skip to main content
. 2018 Feb 28;16:29. doi: 10.1186/s12916-018-1017-7

Fig. 2.

Fig. 2

Overview of the troxacitabine trial using a response-adaptive randomisation design. The probabilities shown are those at the time the patient on the x-axis was randomised. Coloured numbers indicate the arms to which the patients were randomised